vimarsana.com

Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Temple University ,Pennsylvania ,United States ,Bucks County ,New Jersey ,Philadelphia ,Kostenloser Wertpapierhandel ,Thoma Kikis ,Louie Toma ,Kannalifea Neuropathix ,Douglas Brenneman ,Mark Mcdonnell ,Doug Brenneman ,Temple University Center ,Ready The Company To Begin ,Pennsylvania Biotechnology Center ,Company Twitter ,Lewis Katz School Of Medicine ,Initiative Helping End Addiction ,Development Of Therapies ,Kannalife Sciences Inc ,National Institute Of Neurological Disorders ,National Institute ,Neuropathix Inc ,Substance Abuse Research ,Assets Include Company Non ,National Institutes Of Health ,Temple University Conflict Of Interest ,Drug Administration ,Preclinical Screening Program For Pain ,Company Strategy ,Hepatitisb Foundation ,Blumberg Institute ,Baruchs Blumberg Institute ,Securities Exchange ,Katz School Of Medicine ,Pharmaceutical Assets Include Company ,Non Opioid Anti Inflammatory Compound ,Grant Funds ,Complete Preclinical Studies ,Kannalife Sciences ,Neurological Disorders ,National Institutes ,Helping End Addiction Long Term ,Technologies Directed ,Enhanced Pain Management ,Chief Pharmacologist ,Sara Jane Ward ,Assistant Professor ,Katz School ,Preclinical Screening Program ,Bill Kinney ,Lewis Katz School ,Dean Petkanas ,Neural Sciences ,Global Neuropathic Pain ,Global Opioids Drug ,Philadelphia New Jersey ,Securities Act ,Securities Exchange Act ,Safe Harbor ,United States Controlled Substances ,

vimarsana.com © 2020. All Rights Reserved.